Vinorelbine (VRB) plus gemcitabine (GEM) as first-line treatment for elderly patients (p) with advanced non-small cell lung cancer (NSCLC): Molecular correlates

被引：0
|
作者：
Maestu, I.
Isla, D.
Diz, P.
Munoz, J.
Oramas, J.
Garcia, R.
del Barco, S.
Provencio, M.
Taron, M.
Rosell, R.
机构：
[1] Hosp Virgen de los Lirios, Alcoy, Spain
[2] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[3] Complejo Hosp Leon, Leon, Spain
[4] Hosp Univ Dr Peset, Valencia, Spain
[5] Hosp Univ Tenerife, San Cristobal la Laguna, Spain
[6] Hosp Univ Gregorio Maranon, Madrid, Spain
[7] Hosp Josep Trueta, Girona, Spain
[8] Hosp Puerta de Hierro, Madrid, Spain
[9] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18040
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Vinorelbine (VRL) plus gemcitabine (GEM) as first-line treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC): molecular correlates
    Maestu, I.
    Isla, D.
    Pedraza, M.
    Munoz, J.
    Oramas, J.
    Garcia-Gomez, R.
    del Barco, S.
    Cantos, B.
    Taron, M.
    Rosell, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 384 - 385
  • [2] Cisplatin (CDDP) plus vinorelbine (VRB) as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Molecular correlates
    de las Penas, R.
    Provencio, M.
    Camps, C.
    Cobo, M.
    Massuti, B.
    Jimenez, U.
    Artal, A.
    Cardenal, F.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Cisplatin (CDDP) plus vinorelbine (VRB) as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): molecular correlates
    Provencio, M.
    Blanco, R.
    Alberola, V.
    Delgado, J. R.
    Diz, P.
    Almenarez, J. A.
    Lopez-Vivanco, G.
    Gonzalez-Larriba, J. L.
    Martin, G.
    Rosell, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 384 - 384
  • [4] Gemcitabine (GEM) plus vinorelbine (NVB) in non-small cell lung cancer (NSCLC)
    Michetti, G
    Beretta, GD
    Belometti, MO
    Gritti, G
    Marini, B
    Agazzi, A
    Labianca, R
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 92
  • [5] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [6] ACTIVITY AND TOLERABILITY OF CARBOPLATIN AND GEMCITABINE IN FIRST-LINE TREATMENT OF ELDERLY THAI PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Charoentum, Chaiyut
    Theerakittikul, Theerakorn
    Saeteng, Somcharone
    Euathrongchit, Juntima
    Lertprasertsuke, Nirush
    Ariyawutyakorn, Witthawat
    Chewaskulyong, Busyamas
    Thongprasert, Sumitra
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1313 - S1313
  • [7] Phase II study of gemcitabine plus oxaliplatin as first-line treatment in elderly or unfit patients with advanced non-small cell lung cancer (NSCLC).: Across
    Domènech, M
    Losa, F
    Blanco, R
    Nogué, M
    Montesinos, J
    Mesía, C
    Gallardo, E
    de Olaguer, JP
    LUNG CANCER, 2005, 49 : S242 - S242
  • [8] Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer
    Barón, F
    Cueva, J
    Graña, B
    Curiel, T
    León, L
    Vázquez, F
    Candamio, S
    López, R
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) : 1381 - 1384
  • [9] A pilot-study with gemcitabine (GEM), vinorelbine (VNR) and cisplatin (P) in the treatment of advanced non-small cell lung cancer (NSCLC).
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Müller, T
    Scholtze, J
    Graeven, U
    Hirth, M
    Hossfeld, DK
    ANNALS OF ONCOLOGY, 2000, 11 : 115 - 115
  • [10] Phase II study of gemcitabine plus oxaliplatin as first-line treatment in elderly or unfit patients with advanced non-small cell lung cancer (NSCLC). The ACROSS Study
    Domenech, Montse
    Losa, Ferran
    Blanco, Remei
    Nogue, Miquel
    Montesinos, Jesus
    Mesia, Carles
    Gallardo, Enrique
    Perez de Olaguer, Joaquim
    ANNALS OF ONCOLOGY, 2004, 15 : 177 - 177
12345